SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000944809-17-000008
Filing Date
2017-08-08
Accepted
2017-08-08 16:15:59
Documents
77
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q opk-6302017x10q.htm 10-Q 1334140
2 EXHIBIT 31.1 copyofopk-3312017xex311.htm EX-31.1 11883
3 EXHIBIT 31.2 copyofopk-3312017xex312.htm EX-31.2 11893
4 EXHIBIT 32.1 copyofopk-3312017xex321.htm EX-32.1 4433
5 EXHIBIT 32.2 copyofopk-3312017xex322.htm EX-32.2 4678
  Complete submission text file 0000944809-17-000008.txt   9227064

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT opk-20170630.xml EX-101.INS 2109368
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20170630.xsd EX-101.SCH 61758
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20170630_cal.xml EX-101.CAL 108866
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20170630_def.xml EX-101.DEF 448781
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20170630_lab.xml EX-101.LAB 899021
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20170630_pre.xml EX-101.PRE 569979
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 171014934
SIC: 2834 Pharmaceutical Preparations